(1R,2R)-N-(cyanomethyl)-4,4-difluoro-2-(morpholine-4-carbonyl)cyclopentanecarboxamide

ID: ALA3093938

PubChem CID: 76328142

Max Phase: Preclinical

Molecular Formula: C13H17F2N3O3

Molecular Weight: 301.29

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N#CCNC(=O)[C@@H]1CC(F)(F)C[C@H]1C(=O)N1CCOCC1

Standard InChI:  InChI=1S/C13H17F2N3O3/c14-13(15)7-9(11(19)17-2-1-16)10(8-13)12(20)18-3-5-21-6-4-18/h9-10H,2-8H2,(H,17,19)/t9-,10-/m1/s1

Standard InChI Key:  QQZWOQHJYKFJNF-NXEZZACHSA-N

Molfile:  

     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
   11.8914   -6.1311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2763   -6.6692    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.0499   -6.9328    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.6718   -5.8887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6842   -5.0715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9081   -4.8078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4220   -5.4636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3522   -4.6007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6644   -4.0277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2182   -3.4267    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8671   -3.8487    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6244   -3.0639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8309   -2.8838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2739   -3.4822    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5159   -4.2637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3150   -4.4468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0939   -4.9437    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2784   -3.7868    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7618   -4.4729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5035   -4.8160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2445   -5.1569    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  3  1  0
  1  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  1  1  0
  5  8  1  6
  6  9  1  1
  9 10  2  0
  9 11  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  8 17  1  0
  8 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  3  0
M  END

Associated Targets(Human)

CTSK Tchem Cathepsin K (3011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

A20 (109 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 301.29Molecular Weight (Monoisotopic): 301.1238AlogP: 0.15#Rotatable Bonds: 3
Polar Surface Area: 82.43Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.77CX Basic pKa: CX LogP: -1.47CX LogD: -1.47
Aromatic Rings: Heavy Atoms: 21QED Weighted: 0.75Np Likeness Score: -1.34

References

1. Hilpert H, Mauser H, Humm R, Anselm L, Kuehne H, Hartmann G, Gruener S, Banner DW, Benz J, Gsell B, Kuglstatter A, Stihle M, Thoma R, Sanchez RA, Iding H, Wirz B, Haap W..  (2013)  Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffolds.,  56  (23): [PMID:24224654] [10.1021/jm401528k]

Source